Abstract:Targeted protein degradation utilizing a bifunctional molecule to initiate ubiquitination and subsequent degradation by the 26S proteasome has been shown to be a powerful therapeutic intervention. Many bifunctional molecules, including covalent and non-covalent ligands to proteins of interest, have been developed. The traditional target protein degradation methodology targets the protein of interest in both healthy and diseased cell populations, and a therapeutic window is obtained based on the overexpression of the targeted protein. We report here a series of bifunctional degraders that do not rely on interacting with an E3 ligase, but rather a 26S proteasome subunit, which we have named ByeTACs: Bypassing E3 Targeting Chimeras. Rpn-13 is a non-essential ubiquitin receptor for the 26S proteasome. Cells under significant stress or require significant ubiquitin-dependent degradation of proteins for survival, incorporate Rpn-13 in the 26S to increase protein degradation rates. The targeted protein degraders reported here are bifunctional molecules that include a ligand to Rpn-13 and BRD4, the protein of interest we wish to degrade. We synthesized a suite of degraders with varying PEG chain lengths and showed that bifunctional molecules that incorporate a Rpn-13 binder (TCL1) and a BRD4 binder (JQ1) with a PEG linker of 3 or 4 units are the most effective to induce BRD4 degradation. We also demonstrate that our new targeted protein degraders are dependent upon proteasome activity and Rpn-13 expression levels. This establishes a new mechanism of action for our ByeTACs that can be employed for the targeted degradation of a wide variety of protein substrates.

ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Targeted protein degradation via intramolecular bivalent glues

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras

Bifunctional Peptide Nanofibrils for Targeted Protein Degradation.

A covalent BTK ternary complex compatible with targeted protein degradation

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

Leveraging dual-ligase recruitment to enhance degradation via a heterotrivalent PROTAC

Bivalent Ligands for Protein Degradation in Drug Discovery

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

An in-cell approach to evaluate E3 ligases for use in targeted protein degradation.

DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders

Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2

Temporal and Spatial Characterization of CUL3KLHL20-driven Targeted Degradation of BET family, BRD Proteins by the Macrocycle-based Degrader BTR2004

PROTAC-induced Protein Structural Dynamics in Targeted Protein Degradation

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3

A modular PROTAC design for target destruction using a degradation signal based on a single amino acid

An all-in-one targeted protein degradation platform guided by degradation condensates-bridging bi-specific nanobodies

Targeted protein degradation: expanding the toolbox

Diverse Amine-Acid Coupling Reactions Modulate the Potency of BRD4 PROTACs